Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T19:01:25.524Z.
Calculation as of: 2026-10-06T19:01:25.524Z.
Quote observation: 2026-10-06T19:00:09.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e7bb4fe4bb3aa983eb4620adc8aa5d0f555a5020ff21ce65ee2b72f9631e0f85
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$2.80B
EV/EBIT Ratio
39.10x
TTM Avg
46.98x
3Y Avg
64.49x
5Y Avg
64.49x
Market Cap
$2.78B
EV/EBIT Ratio
192.86x
TTM Avg
169.00x
3Y Avg
169.00x
5Y Avg
169.00x
Market Cap
$3.01B
EV/EBIT Ratio
90.31x
TTM Avg
650.30x
3Y Avg
650.30x
5Y Avg
650.30x
Market Cap
$3.09B
EV/EBIT Ratio
N/A
TTM Avg
9.47x
3Y Avg
9.47x
5Y Avg
9.47x
Market Cap
$2.67B
EV/EBIT Ratio
14.95x
TTM Avg
12.41x
3Y Avg
11.52x
5Y Avg
10.90x
Market Cap
$3.09B
EV/EBIT Ratio
N/A
TTM Avg
142.94x
3Y Avg
142.94x
5Y Avg
142.94x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | $2.88B | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.80B | 39.10x | 46.98x | 64.49x | 64.49x |
| AtriCure, Inc. (ATRC)vs › | $2.78B | 192.86x | 169.00x | 169.00x | 169.00x |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.01B | 90.31x | 650.30x | 650.30x | 650.30x |
| Precigen, Inc. (PGEN)vs › | $2.74B | N/A | N/A | N/A | N/A |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.06B | N/A | N/A | N/A | N/A |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.09B | N/A | 9.47x | 9.47x | 9.47x |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.67B | 14.95x | 12.41x | 11.52x | 10.90x |
| Denali Therapeutics Inc. (DNLI)vs › | $3.09B | N/A | 142.94x | 142.94x | 142.94x |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.66B | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
